These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15156413)

  • 41. [Diabetic macroangiopathy and NO].
    Hayashi T; Iguchi A
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():548-54. PubMed ID: 15506447
    [No Abstract]   [Full Text] [Related]  

  • 42. The effects of alpha-lipoic acid on nitric oxide synthetase dispersion in penile function in streptozotocin-induced diabetic rats.
    Hurdag C; Ozkara H; Citci S; Uyaner I; Demirci C
    Int J Tissue React; 2005; 27(3):145-50. PubMed ID: 16372481
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Upregulation of endothelial nitric oxide synthase maintains nitric oxide production in the cerebellum of thioacetamide cirrhotic rats.
    Hernández R; Martínez-Lara E; Del Moral ML; Blanco S; Cañuelo A; Siles E; Esteban FJ; Pedrosa JA; Peinado MA
    Neuroscience; 2004; 126(4):879-87. PubMed ID: 15207323
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tetrahydrobiopterin: regulator of endothelial nitric oxide synthase in vascular disease.
    Channon KM
    Trends Cardiovasc Med; 2004 Nov; 14(8):323-7. PubMed ID: 15596110
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Therapeutic strategies in the treatment of endothelial dysfunction: facts and outlook].
    Puddu P
    Ital Heart J Suppl; 2000 Feb; 1(2):212-21. PubMed ID: 10731378
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathogenesis of angiopathy in diabetes.
    Skrha J
    Acta Diabetol; 2003 Dec; 40 Suppl 2():S324-9. PubMed ID: 14704862
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Obesity, atherosclerosis and the vascular endothelium: mechanisms of reduced nitric oxide bioavailability in obese humans.
    Williams IL; Wheatcroft SB; Shah AM; Kearney MT
    Int J Obes Relat Metab Disord; 2002 Jun; 26(6):754-64. PubMed ID: 12037644
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endothelial dysfunction in chronic heart failure: some new basic mechanisms.
    Bachetti T
    Ital Heart J; 2000 Oct; 1(10):656-61. PubMed ID: 11061361
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endothelial dysfunction in normal and abnormal glucose metabolism.
    Esper RJ; Vilariño JO; Machado RA; Paragano A
    Adv Cardiol; 2008; 45():17-43. PubMed ID: 18230954
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of nitric oxide in diabetic nephropathy.
    Prabhakar SS
    Semin Nephrol; 2004 Jul; 24(4):333-44. PubMed ID: 15252773
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diabetes and vascular disease: basic concepts of nitric oxide physiology, endothelial dysfunction, oxidative stress and therapeutic possibilities.
    Capellini VK; Celotto AC; Baldo CF; Olivon VC; Viaro F; Rodrigues AJ; Evora PR
    Curr Vasc Pharmacol; 2010 Jul; 8(4):526-44. PubMed ID: 19485895
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Vascular endothelial cell dysfunction in diabetes mellitus].
    Fujita H
    Nihon Rinsho; 1999 Mar; 57(3):573-7. PubMed ID: 10199136
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endothelial dysfunction and its role in diabetic vascular disease.
    Hartge MM; Kintscher U; Unger T
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):551-60, viii-ix. PubMed ID: 16959585
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Possible pathophysiological mechanisms for diabetic angiopathy in type 2 diabetes.
    Tooke JE
    J Diabetes Complications; 2000; 14(4):197-200. PubMed ID: 11004428
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Endothelial dysfunction and plaque inflammation in diabetic macroangiopathy].
    Ikura Y; Kitabayashi C; Ueda M
    Nihon Rinsho; 2006 Nov; 64(11):1980-3. PubMed ID: 17087286
    [No Abstract]   [Full Text] [Related]  

  • 56. [Physical activity and endothelial dysfunction in type 2 diabetic patients: the role of nitric oxide and oxidative stress].
    Brinkmann C; Schwinger RH; Brixius K
    Wien Med Wochenschr; 2011 Jun; 161(11-12):305-14. PubMed ID: 21360292
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Therapeutic targets in diabetic vasculopathy].
    Sánchez Ferrer CF
    An R Acad Nac Med (Madr); 2003; 120(4):659-69; discussion 669-74. PubMed ID: 15147053
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The atherosclerotic process and its exacerbation by diabetes.
    Baumgartl HJ; Standl E
    Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S487-92. PubMed ID: 11460593
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies.
    Pacher P; Obrosova IG; Mabley JG; Szabó C
    Curr Med Chem; 2005; 12(3):267-75. PubMed ID: 15723618
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The physiology and pathophysiology of the nitric oxide/superoxide system.
    Münzel T; Heitzer T; Harrison DG
    Herz; 1997 Jun; 22(3):158-72. PubMed ID: 9232165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.